
Please try another search
Aratana Therapeutics, Inc. (NASDAQ:PETX) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $4.02 – $6.55 in the past one-month time frame, witnessed a sharp increase on Friday.
The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Aratana Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Aratana Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Another stock worth considering in the Medical – Drugs industry is Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is PETX going up? Or down? Predict to see what others think: Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
US Indexes have done well this year despite a negative backdrop And history suggests their good performance is set to continue With that in mind, here are three stocks that Wall...
Tuesday’s Daily was all about the metals. Wednesday, gold, miners, and silver all rallied. Is the bottom in on this last correction? Perhaps. Two interesting areas to watch now are...
The S&P 500 slipped 0.6% as Congress moved toward resolving the debt ceiling crisis. This negotiated compromise finally lifts the clouds that have been hanging over stocks for...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.